Teachers Advisors’s CASI Pharmaceuticals CASI Stock Holding History

Teachers Advisors’s Portfolio CASI Stock Details CASI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$308K	Hold	10,742	–	–	﹤0.01%	2718
2018 Q4	$432K	Hold	10,742	–	–	﹤0.01%	2569
2018 Q3	$502K	Buy	10,742 +1,181	+12%	+$82.4K	﹤0.01%	2639
2018 Q2	$787K	Buy	+9,561	New	+$645K	﹤0.01%	2453

Other funds holding CASI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WSCM

Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return

WSC

Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Teachers Advisors's CASI Position: Q1 2019 in Review

Teachers Advisors held its CASI Pharmaceuticals (CASI) position steady in Q1 2019 at 10,742 shares worth $308K. The position accounts for ﹤0.01% of the portfolio, ranked #2718.

Teachers Advisors first reported a position in CASI in Q2 2018 and has held it in 4 quarters since. The position peaked at $787K in Q2 2018. 52 funds tracked by Wall St. Rank hold CASI as of Q1 2019.

Teachers Advisors held 10,742 shares of CASI Pharmaceuticals worth $308K as of Q1 2019.
Teachers Advisors left its CASI Pharmaceuticals share count unchanged in Q1 2019.
CASI Pharmaceuticals made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2718 holding.
Teachers Advisors first reported a position in CASI Pharmaceuticals in Q2 2018 and has held it in 4 quarters since.
Teachers Advisors's CASI Pharmaceuticals position peaked at $787K in Q2 2018.
52 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.